Among the underlying components of the S&P 500 index, we saw noteworthy options trading volume today in Biogen Idec Inc (NASD: BIIB), where a total of 33,741 contracts have traded so far, representing approximately 3.4 million underlying shares. That amounts to about 229.8% of BIIB's average daily trading volume over the past month of 1.5 million shares. Particularly high volume was seen for the $480 strike call option expiring March 20, 2015, with 1,492 contracts trading so far today, representing approximately 149,200 underlying shares of BIIB. Below is a chart showing BIIB's trailing twelve month trading history, with the $480 strike highlighted in orange:
Nike (NYSE: NKE) saw options trading volume of 70,567 contracts, representing approximately 7.1 million underlying shares or approximately 198% of NKE's average daily trading volume over the past month, of 3.6 million shares.
Particularly high volume was seen for the $102 strike call option expiring March 20, 2015, with 7,781 contracts trading so far today, representing approximately 778,100 underlying shares of NKE. Below is a chart showing NKE's trailing twelve month trading history, with the $102 strike highlighted in orange:
And Tiffany & Co. (NYSE: TIF) options are showing a volume of 28,237 contracts thus far today. That number of contracts represents approximately 2.8 million underlying shares, working out to a sizeable 153.6% of TIF's average daily trading volume over the past month, of 1.8 million shares.
Especially high volume was seen for the $85 strike put option expiring March 20, 2015, with 3,761 contracts trading so far today, representing approximately 376,100 underlying shares of TIF. Below is a chart showing TIF's trailing twelve month trading history, with the $85 strike highlighted in orange:
For the various different available expirations for BIIB options, NKE options, or TIF options, visit StockOptionsChannel.com.
Special Offer: Join the income investing conversation on ValueForum.com with a special Seven Days for Seven Dollars invitation from Forbes.
